Bonadio, R. R. da C. C. (2026) “Dose-dense versus 3-weekly ac during neoadjuvant chemoimmunotherapy for early-stage triple-negative breast cancer: GBECAM 0123 – the neo-real study”, Mastology. Rio de Janeiro, 34(suppl. 1). doi: 10.29289/259453942024V34S1014.